相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Findings from a Genetic Sequencing Investigation of Men with Familial and Aggressive Prostate Cancer
Burcu F. Darst
EUROPEAN UROLOGY (2021)
Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer
Burcu F. Darst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
A Population-Based Study of Genes Previously Implicated in Breast Cancer
Chunling Hu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women
Leila Dorling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
PALB2 mutations and prostate cancer risk and survival
Dominika Wokolorczyk et al.
BRITISH JOURNAL OF CANCER (2021)
The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in Canada
Steven A. Narod et al.
CANCERS (2021)
Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer
Rebeca Lozano et al.
BRITISH JOURNAL OF CANCER (2021)
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
Mev Dominguez-Valentin et al.
GENETICS IN MEDICINE (2020)
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study
Tommy Nyberg et al.
EUROPEAN UROLOGY (2020)
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Xin Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Olaparib for Metastatic Castration-Resistant Prostate Cancer
J. de Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Veda N. Giri et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland
Dominika Wokolorczyk et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
Wassim Abida et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017
David A. Siegel et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening
N. Segal et al.
ANNALS OF ONCOLOGY (2020)
Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
Piper Nicolosi et al.
JAMA ONCOLOGY (2019)
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
Elizabeth C. Page et al.
EUROPEAN UROLOGY (2019)
The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists
Carmen Bergom et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer
H. Ballentine Carter et al.
EUROPEAN UROLOGY (2019)
Homeobox B13 G84E Mutation and Prostate Cancer Risk
Tommy Nyberg et al.
EUROPEAN UROLOGY (2019)
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer
Gillian Vandekerkhove et al.
EUROPEAN UROLOGY (2019)
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer
Elena Castro et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
Wassim Abida et al.
JAMA ONCOLOGY (2019)
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
Pal Moller et al.
GUT (2018)
Eighteen-year follow-up of the Goteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality
Jonas Hugosson et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2018)
Pathogenic Germline Variants in 10,389 Adult Cancers
Kuan-lin Huang et al.
CELL (2018)
Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review
K. J. Jerzak et al.
CURRENT ONCOLOGY (2018)
Male Oncology Research and Education program for men at high risk for prostate cancer
J. Lorentz et al.
CURRENT ONCOLOGY (2018)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher et al.
NATURE GENETICS (2018)
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Matti Annala et al.
CANCER DISCOVERY (2018)
Cancer Risks for PMS2-Associated Lynch Syndrome
Sanne W. ten Broeke et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap
Jeanna M. McCuaig et al.
JOURNAL OF MEDICAL GENETICS (2018)
Extended Mortality Results for Prostate Cancer Screening in the PLCO Trial With Median Follow-Up of 15 Years
Paul F. Pinsky et al.
CANCER (2017)
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
Rong Na et al.
EUROPEAN UROLOGY (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores
Julie Lecarpentier et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)
Philipp Harter et al.
PLOS ONE (2017)
Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline
N. J. H. van Os et al.
CLINICAL GENETICS (2016)
A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment
Leonard P. Bokhorst et al.
EUROPEAN UROLOGY (2016)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
C. C. Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes
Z. Kote-Jarai et al.
ANNALS OF ONCOLOGY (2015)
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci
Ali Amin Al Olama et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Active surveillance for the management of localized prostate cancer: Guideline recommendations
Chris Morash et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2015)
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
Elena Castro et al.
EUROPEAN UROLOGY (2015)
CHEK2 mutations and the risk of papillary thyroid cancer
Monika Siolek et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
Laurence Klotz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer
M. R. Akbari et al.
BRITISH JOURNAL OF CANCER (2014)
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
D. Leongamornlert et al.
BRITISH JOURNAL OF CANCER (2014)
Risk of Prostate Cancer in Lynch Syndrome: A Systematic Review and Meta-analysis
Shae Ryan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
CHEK2* 1100delC Mutation and Risk of Prostate Cancer
Victoria Hale et al.
PROSTATE CANCER (2014)
An inherited NBN mutation is associated with poor prognosis prostate cancer
C. Cybulski et al.
BRITISH JOURNAL OF CANCER (2013)
HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Virpi H. Laitinen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial
Zhuo Chen et al.
CARCINOGENESIS (2013)
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)
Jianfeng Xu et al.
HUMAN GENETICS (2013)
Elevated Risk of Prostate Cancer Among Men With Lynch Syndrome
Victoria M. Raymond et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
Elena Castro et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Long-Term Survival of Participants in the Prostate Cancer Prevention Trial
Ian M. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland
Wojciech Kluzniak et al.
PROSTATE (2013)
Germline BRCA1 mutations increase prostate cancer risk
D. Leongamornlert et al.
BRITISH JOURNAL OF CANCER (2012)
Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome
Christoph Engel et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Association Between Germline HOXB13 G84E Mutation and Risk of Prostate Cancer
Mohammad R. Akbari et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Charles M. Ewing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
Z. Kote-Jarai et al.
BRITISH JOURNAL OF CANCER (2011)
Characterising the castration-resistant prostate cancer population: a systematic review
M. Kirby et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
Valerie Bonadona et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Eric A. Klein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
Cezary Cybulski et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Effect of Dutasteride on the Risk of Prostate Cancer.
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CHEK2 1100delC and male breast cancer in the Netherlands
Marijke Wasielewski et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Germ-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer
Eli Marie Grindedal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations
E. Barrow et al.
CLINICAL GENETICS (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
A. Mitra et al.
BRITISH JOURNAL OF CANCER (2008)
The VIOXX in prostate cancer prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups
Janet van Adelsberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Prostate cancer progression and survival in BRCA2 mutation carriers
Laufey Tryggvadottir et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer
JA Cesaretti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
The complex genetic epidemiology of prostate cancer
DJ Schaid
HUMAN MOLECULAR GENETICS (2004)
Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: A review of the literature
A Liede et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy
CM Gonzalez et al.
UROLOGY (2004)
ATM polymorphisms as risk factors for prostate cancer development
S Angèle et al.
BRITISH JOURNAL OF CANCER (2004)
Relative risk of prostate cancer for men with affected relatives: Systematic review and meta-analysis
DW Bruner et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
CHEK2 variants associate with hereditary prostate cancer
EH Seppälä et al.
BRITISH JOURNAL OF CANCER (2003)
Mutations in CHEK2 associated with prostate cancer risk
XY Dong et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Cancer control with radical prostatectomy alone in 1,000 consecutive patients
GW Hull et al.
JOURNAL OF UROLOGY (2002)
ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects
CM Iannuzzi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling
A Liede et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued rise of biochemical failure after 5 years
CL Amling et al.
JOURNAL OF UROLOGY (2000)
分享论文
